Bad cholesterol inhibits the breakdown of peripheral fat
The so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet. The discovery reveals a novel function of LDL as a regulator of fat turnover besides its well-established detrimental effects in promoting atherosclerosis.
The study, which is a collaboration of two research groups at Karolinska Institutet, is published in PLoS ONE. It shows that LDL cholesterol slows the rate of fat breakdown (i.e. lipolysis) in adipocytes, the peripheral cells responsible for fat storage. Previously, it has been known that release of free fatty acid from the peripheral fat to the blood stream increases the synthesis of LDL precursors in the liver.
“The results of our study provide evidence of a reciprocal link between the liver and peripheral fat regulating fat turnover”, says study-initiator Dr Johan Björkegren.
The discovery also opens up for new theories for the well-established association between blood lipids and the metabolic syndrome.
“If proven of general physiological importance, therapies lowering LDL, as for instances Statins, may also affect the turnover of peripheral fat,” continues Dr Björkegren.
The study and has been performed on cell cultures and tissues from humans as well as mouse models with different levels of LDL. The inhibitory effect was also shown to be dependent on LDL receptors on the surface of the fat cells.
“The exact intracellular mechanism for how the binding of LDL to the surface of the fat cells inhibits the breakdown of intracellular fat remains to be revealed”, say project leader Dr Josefin Skogsberg
Original publication: Josefin Skogsberg, Andrea Dicker, Mikael Rydén, Gaby Åström, Roland Nilsson, Hasanuzzaman Bhuiyan, Sigurd Vitols, Aline Mairal, Dominique Langin, Peteris Alberts, Erik Walum, Jesper Tegnér, Anders Hamsten, Peter Arner, Johan Björkegren; "ApoB100-LDL Acts as a Metabolic Signal from Liver to Peripheral Fat Causing Inhibition of Lipolysis in Adipocytes”; PLoS ONE 2008.
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Magnetic resonance imaging shows brain inflammation in vivo for the first time - Researchers have obtained for the first time images of the activation of microglia and astrocytes
Emerson_College_of_Herbology
Category:Cat_registries

Nanoparticles can change cells
Tecan signs agreement with South African Police Service to provide a fully automated DNA typing system

I was here first! This is how hepatitis C inhibits hepatitis E - A single protein from one virus can prevent infection with another virus in cell culture
Large conformational changes without ATP consummation - Energy saving chaperone Hsp90

ACCEL Instruments GmbH - Bergisch Gladbach, Germany
Marina_Karaseva
MBL scientists find genes linked to human neurological disorders in sea lamprey genome - Discovery will accelerate research on Alzheimer's disease, Parkinson's disease and spinal cord injury
Genomatix Expands Operations in North America - New Subsidiary and Training Academy in Ann Arbor, MI
